Table 1 |
|
Common features of 'treatment-refractory' gout that complicate management |
|
Polyarticular gout, uncontrolled flare activity, and/or chronic synovitis |
|
Destructive tophi |
|
Advanced age |
|
Co-morbidities (for example, chronic kidney disease, cardiovascular disease, obesity, metabolic syndrome or diabetes, alcohol abuse) |
|
Polypharmacy and drug interactions (for example, statins, macrolide antibiotics, oral anticoagulants) |
|
Contra-indications or refractoriness to NSAIDs, colchicines, and/or glucocorticosteroids |
|
Allopurinol intolerance or hypersensitivity and inability to employ uricosurics |
|
Failure to adequately lower serum urate on appropriate doses of urate-lowering drugs |
|
|
|
NSAID, nonsteroidal anti-inflammatory drug. |
|
Terkeltaub Arthritis Research & Therapy 2009 11:236 doi:10.1186/ar2738 |